For research use only. Not for therapeutic Use.
Brentuximab is a chimeric antibody targeting CD30. Brentuximab can be used for the research of emerging targeted therapies[1].
| Catalog Number | I043224 |
| CAS Number | 2088770-90-3 |
| Purity | ≥95% |
| Reference | [1]. Oh Y, et al. Part II: Prognosis and management. J Am Acad Dermatol. 2021 Nov;85(5):1093-1106. |
